Last reviewed · How we verify
Antioxidant formula
At a glance
| Generic name | Antioxidant formula |
|---|---|
| Also known as | AOF (Vega Natural, Konya, Turkey) |
| Sponsor | Bagcilar Training and Research Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction (PHASE2, PHASE3)
- Adherence to Lifestyle Changes for Age-related Macular Degeneration (NA)
- Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients (PHASE3)
- Formulation, Phytochemical Characterization, and Clinical Assessment of a Novel Natural Supplement Targeting Body Composition in Physically Active Individuals (NA)
- Feasibility and Acceptability of Powdered Multinutrient Formula (NA)
- Dietary Supplement on the Intestinal Microbiota in Patients with Colon Cancer (NA)
- Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE) (PHASE1)
- Role of Antioxidants in the Reduction of Oxidative Stress in Infertile Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antioxidant formula CI brief — competitive landscape report
- Antioxidant formula updates RSS · CI watch RSS
- Bagcilar Training and Research Hospital portfolio CI